Home / Peptide legality / By country / Brazil
Are peptides legal in Brazil?
Peptides are restricted in Brazil: they are legal only as ANVISA-registered prescription medicines, while research/compounding peptides such as BPC-157 and TB-500 are unregistered and cannot be lawfully sold or imported for human use.
Legal status overview
Peptides are restricted in Brazil, legal only when they are prescription medicines registered with the national health regulator ANVISA (Agência Nacional de Vigilância Sanitária). ANVISA has publicly warned that popular research peptides like BPC-157, TB-500, CJC-1295, ipamorelin and GHK-Cu are not registered in any category (medicine, supplement or cosmetic) and therefore cannot be sold, while GLP-1 drugs (semaglutide) are available only as registered, prescription medicines after ANVISA banned their compounded versions in 2025.
Key points
- ANVISA has publicly declared that injectable peptides such as BPC-157, TB-500, GHK-Cu, CJC-1295 and ipamorelin are not registered in any category and cannot be commercialized for health or aesthetic use in Brazil. [1]
- ANVISA classifies BPC-157 and TB-500 as unregularized experimental substances that are illegal for any use in health in Brazil, including aesthetic use. [2]
- ANVISA banned pharmacy compounding of semaglutide (the active ingredient of Ozempic®, Wegovy® and Rybelsus®) in August 2025 via Despacho 97/2025, because no synthetic semaglutide medicine is registered in Brazil, making such compounding irregular and illegal. [3]
- ANVISA's 2025 rules tie compounding of GLP-1 peptides to registration: a synthetic active ingredient may only be compounded if a registered medicine in Brazil already uses that molecule, and ANVISA kept tirzepatide compounding permitted under stricter import and quality-control conditions. [4]
- Personal importation of peptides without approval by an equivalent foreign regulator (FDA, EMA) or ANVISA is prohibited in Brazil, so unapproved research peptides like BPC-157 cannot be legally imported by an individual outside of an approved clinical trial or compassionate-use pathway (RDC 38/2013). [5]
- ANVISA permits personal importation of medicines by an individual only when Brazilian legal requirements are met, including a valid medical prescription and, generally, registration of the product in the country of origin. [6]
- Peptides that qualify as medicines with controlled substances fall under Brazil's special-control framework (Portaria SVS/MS nº 344/98), which requires a special-control prescription that is retained at the pharmacy on dispensing. [7]
Compound-by-compound status
| BPC-157 | BPC-157 is illegal to sell in Brazil: ANVISA states it has no registration as a medicine, supplement or cosmetic and cannot be commercialized for any health or aesthetic use. [1] |
|---|---|
| TB-500 | TB-500 is an unregistered experimental substance in Brazil that ANVISA considers illegal for any use in health, including aesthetic purposes. [2] |
| Semaglutide (GLP-1, e.g. Ozempic®/Wegovy®) | Semaglutide is legal in Brazil only as an ANVISA-registered, prescription medicine, and ANVISA banned pharmacy-compounded versions in August 2025. [3] |
| Tirzepatide (GLP-1/GIP, Mounjaro®) | Tirzepatide is legal in Brazil as a registered prescription medicine and, unlike semaglutide, its pharmacy compounding remained permitted under ANVISA's 2025 rules subject to stricter import and quality-control requirements. [4] |
| Human growth hormone (HGH/somatropin) | HGH/somatropin is available in Brazil only as a registered prescription medicine subject to special controls, and no source found in this research directly documents its scheduling detail, so this reflects the general prescription-medicine framework rather than a peptide-specific statute. (no source found) |
Frequently asked questions
Can I buy peptides in Brazil without a prescription?
No. In Brazil peptides are legal only as ANVISA-registered prescription medicines; research peptides such as BPC-157, TB-500, CJC-1295 and ipamorelin are not registered in any category and cannot lawfully be sold at all, with or without a prescription. [1]
Can I legally import peptides into Brazil for personal use?
Only registered medicines can be imported for personal use in Brazil, and only with a valid prescription and (generally) approval in the country of origin; unapproved research peptides like BPC-157 cannot be legally imported by an individual outside an approved clinical trial or compassionate-use route (RDC 38/2013). [5]
Is compounded (manipulated) semaglutide legal in Brazil?
No. ANVISA banned compounded semaglutide in August 2025 (Despacho 97/2025) because no synthetic semaglutide medicine is registered in Brazil, making the compounded versions irregular and illegal; only registered semaglutide products such as Ozempic® and Wegovy® may be dispensed. [3]
Is BPC-157 legal in Brazil?
No. ANVISA states BPC-157 has no registration as a medicine, supplement or cosmetic and treats it as an experimental substance that is illegal for any health or aesthetic use in Brazil. [1]
How can someone legally obtain peptide medicines in Brazil?
The lawful pathway in Brazil is a prescription for an ANVISA-registered peptide medicine (such as semaglutide, tirzepatide or somatropin), which for controlled substances requires a special-control prescription retained at the pharmacy under Portaria SVS/MS nº 344/98. [7]
Sources
- Metrópoles, Anvisa alerta que peptídeos injetáveis vendidos online são ilegais (retrieved 2026-09-22)
- Futuro da Saúde, Peptídeos experimentais viram tendência, mesmo sem comprovação científica (retrieved 2026-09-22)
- Agência Brasil, Anvisa proíbe versões manipuladas da semaglutida, usada no Ozempic® (retrieved 2026-09-22)
- APM, Anvisa proíbe manipulação de Ozempic®, Wegovy® e Rybelsus® (retrieved 2026-09-22)
- pephealth, Importação de peptídeos: o que diz a lei BR (retrieved 2026-09-22)
- ANVISA, Anvisa garante acesso a medicamentos importados (retrieved 2026-09-22)
- Conselho Regional de Farmácia de São Paulo (CRF-SP), Portaria SVS/MS nº 344/98 (retrieved 2026-09-22)
Last researched: 2026-09-22.